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Objective: Small patient numbers, mixed data from clinical trials, and longitudinal series representing institutional
learning curves have characterized previous studies of early outcomes after endovascular abdominal aortic aneurysm
(AAA) repair. We compared the perioperative outcomes of endovascular and open surgical AAA repair in an unselected
sample of patients in a single calendar year using a national administrative database.
Methods: The 2001 National Inpatient Sample database was retrospectively reviewed. This database represents 20% of
all-payer stratified sample of non-federal US hospitals. Patients older than 49 years were identified by primary diagnostic
codes (International Classification of Disease, ninth revision [ICD-9], 441.4, intact, nonruptured AAA) and procedure
codes (ICD-9 38.44 for open, 39.71 for endovascular repair). Patient demographic data (age, sex), comorbid conditions
(ICD-9 coded), inpatient complications (ICD-9 coded), length of stay, final discharge disposition (home vs institution vs
death), and hospital charges were examined with univariate and multivariate analyses.
Results: In calendar year 2001, 7172 patients underwent either open (64%) or endovascular (36%) repair of intact,
nonruptured AAAs. Despite comparable rates of preoperative comorbid conditions and a greater proportion of
octogenarians (23% vs 16%%; P  .0001), morbidity (18% vs 29%; P  .0001) and mortality (1.3% vs 3.8%; P  .0001)
were significantly lower for endovascular repair than for open repair. The median length of stay (2 vs 7 days; P  .0001)
and the rate of discharge to an institutional facility versus home (6% vs 14%; P  .0001) were also much lower in the
endovascular group than in the open repair group. At multivariate analysis, open AAA repair and age older than 80 years
were strong independent predictors (P  .0001 for all) for death (open repair: odds ratio [OR], 3.3; 95% confidence
interval [CI], 2.3-4.9; age: OR, 14.2; 95% CI, 3.5-58.1), complications (open repair: OR, 1.9; 95% CI, 1.7-2.1; age: OR,
1.9; 95% CI, 1.5-2.5), and not being discharged to home (open repair: OR, 3.4; 95% CI, 2.9-4.1; age: OR, 12.0; 95% CI,
7.0-20.4). Mean hospital charges were significantly greater (difference, $3337; P  .0009) for endovascular repair than
for open repair. Extrapolated to the total number of endovascular AAA repairs performed during the single 2001
calendar year, this resulted in a staggering $50.3 million in additional hospital charges.
Conclusions: Endovascular repair of intact AAAs results in a significantly lower number of complications and deaths,
shorter hospital stay, and improved likelihood of discharge to home, even in older patients, when compared with open
surgical repair. These impressive gains in clinical outcome, however, are achieved at similarly impressive increases in health
care costs. (J Vasc Surg 2004;39:491-6.)Endovascular stent-graft repair has become an impor-
tant therapeutic alternative for the treatment of abdominal
aortic aneurysm (AAA). While long-term results remain
uncertain, mid-term results with 5 to 6 years of follow-up
have demonstrated efficacy in the prevention of aneurysm
rupture and death from rupture, and equivalent rates of
long-term survival, when compared with open surgical
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doi:10.1016/j.jvs.2003.12.001repair.1 These promising reports of early endovascular suc-
cesses have been tempered by concomitant reports of late
failures involving endoleak,2 migration,3 rupture,4 fabric
tear or stent fracture,5 secondary procedure,6 need for
life-long follow-up,7 and high cost of devices with low
Diagnostic Related Groups (DRG) reimbursement.8
Previous reports that compared initial outcomes after
endovascular versus open surgical AAA repair have pre-
sented conflicting results, because of small numbers of
patients, sampling biases of single-institution series, or clin-
ical experiences skewed by learning curve effects of an
emerging technology.9,10 In most previous studies advan-
tages in secondary surrogate outcome markers, such as
blood loss, procedure time, length of stay, and periopera-
tive morbidity, were shown, but a clear reduction in early
mortality could not be demonstrated.11,12 Indeed, in two491
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ginally lower for endovascular repair compared with open
repair (3% vs 4%, respectively), and the higher systemic or
remote postoperative complications of open repair were
counterbalanced by the increased local or vascular compli-
cations of endovascular repair.13,14
Using a national inpatient administrative database, we
compared early in-hospital outcomes after endovascular
and open AAA repairs. To our knowledge this is the first
report to compare patient outcomes on the basis of a large,
unselected sampling of US clinical practice that represents
an unbiased cross-section of both academic and private
practice, and small and large community-based experience
across the entire country in a single year.
METHODS
Data were obtained for the 2001 calendar year (Jan
1–Dec 31) from the National Inpatient Sample (NIS),
which is the largest all-payer inpatient care database. It is
sponsored by the Agency for Healthcare Research and
Quality, and is used by policy makers to identify, track, and
analyze national trends in health care use, access, charges,
quality, and outcomes. It contains data from more than 7
million annual discharges from 986 hospitals in 33 states,
and approximates a 20% stratified sample of non-federal
community hospitals, representing about 85% of all hospi-
tal discharges in the United States. The discharge abstract
includes the International Classification of Disease, ninth
revision (ICD-9) diagnostic and procedure codes, admis-
sion and discharge status, demographic data, charges (re-
gardless of payer, including persons covered by Medicare,
Medicaid, private insurance, and the uninsured), complica-
tions, and deaths.15
Patients undergoing elective infrarenal AAA repair
were identified by primary diagnostic code (ICD-9 441.4,
intact, non-ruptured AAA) and procedure code (ICD-9
38.44 for open repair, 39.71 for endovascular repair).
Although the first US Food and Drug Administration
–approved commercial endograft systems became available
in September 1999, ICD-9 code 39.71 appeared for the
first time in October 2000; therefore 2001 is the first year in
which endovascular repairs were properly coded for the
purposes of this database. Previous analyses using the pri-
mary diagnostic code 441.4 and all potential procedure
codes for open AAA repair (38.44, 38.34, 38.36, 38.40,
38.46, 38.60, 38.64, 38.66, 38.84, 39.24, 39.25, 39.26,
39.52, 39.56, 39.57) found no difference in mortality or
other trends when compared with procedure code 38.44
alone.16 Patients younger than 50 years and those with
secondary diagnostic codes for ruptured AAA (441.3,
441.5), aortic dissection (441.0), thoracic or thoracoab-
dominal aortic aneurysm (441.1, 441.2, 441.6, 441.7),
coarctation of the aorta (747.1), Marfan syndrome and
other congenital anomalies (759.8), gonadal dysgenesis–
Turner syndrome (758.6), and polyarteritis nodosa
(446.0) were excluded from the analysis.
Outcome measures included mortality, postoperative
complications, length of stay, discharge disposition, andhospital charges. Mortality was defined as in-hospital death,
and complications were identified by ICD-9 codes 996 to
999, which include codes for all complications of medical
and surgical care. The disposition among patients dis-
charged alive was categorized to either home (routine,
home health, against medical advice) or another institu-
tional facility. The charges analyzed reflect only those for
the inpatient hospitalization during which the procedure
was performed.
Univariate analysis for predictors of adverse outcomes
(death, complications, discharge to an institutional facility)
included demographic data, preoperative comorbid condi-
tions, and procedure type (open vs endovascular repair),
and these were presented either as a mean SD or median,
as appropriate. The comorbid conditions were identified
with ICD-9 diagnostic codes for diabetes mellitus (250.0-
250.9), hypertension (401.0-405.9), preoperative renal in-
sufficiency (584.0-586.0, 403.0-403.9), chronic obstruc-
tive pulmonary disease (490.0-496.0), ischemic heart
disease (410.0-414.9), cerebral vascular occlusive disease
(430.0-438.0), and peripheral arterial occlusive disease
(440.0-440.9, 443.0-443.9). Each patient was then cate-
gorized into groups with no or 1, two to three, or four or
more preoperative comorbid conditions. Categorical vari-
ables were compared with the Fisher exact test, and contin-
uous variables were compared with the Student t test and
Wilcoxon signed-rank test, with P .05 considered signif-
icant. Predictors identified as significant at univariate anal-
ysis were incorporated into a multiple logistic regression
model to examine mortality (alive vs dead), any postoper-
ative complication (present vs absent), and discharge status
(home vs institutional facility). Multivariate odds ratios are
reported with 95% confidence intervals. All data analyses
were performed with SAS version 8.0 (SAS Institute, Cary,
NC).
RESULTS
During the 2001 calendar year, 7172 repairs of intact,
nonruptured AAAs were identified in the NIS database. Of
these, 4607 (64%) were open repairs and 2565 (36%) were
endovascular repairs (Table I). Patients who underwent
open repair were significantly younger than those who
underwent endovascular repair. When stratified into de-
cades, relatively more patients in their fifties underwent
open repair than endovascular repair, whereas the reverse
was true for patients in their eighties. Women composed
nearly 20% of all the patients identified, but a significantly
smaller proportion of women underwent endovascular re-
pair compared with open repair. Racial data were available
for only 79% (5697) of the total cases. Within this subset,
the distribution among whites, blacks, and other races
between open and endovascular repairs was similar. Risk
stratification on the basis of the number of comorbid
conditions showed that the two groups were relatively
well-matched with regard to preoperative status. The inci-
dences of the selected cardiovascular comorbid conditions
examined are listed in Table II. Although four of the seven
comorbid conditions technically reached statistical signifi-
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were similar, varying no more than 6% for any single
category.
Comparisons of perioperative outcomes between open
and endovascular repairs are given in Table III. The overall
in-hospital mortality for endovascular repair was signifi-
cantly less than for open repair (1.3% vs 3.8%; P  .0001),
and the rates for all complications and cardiac complica-
tions alone were also significantly lower for endovascular
repair than for open repair. The mean and median length of
stay for endovascular repair was significantly shorter than
for open repair, by 5 days. The most frequent length of stay
for endovascular repair was 1 to 2 days, comprising 58% of
all discharges, whereas for open repair it was 5 to 7 days,
comprising nearly 48% of all discharges (Fig). Among pa-
tients who survived, the rate of discharge to an institutional
facility (vs home) for those with endovascular repair was
nearly one third of that for those with open repair.
Table I. Demographic data for open vs endovascular abdo
Total
n %
7172 100 4
Age (mean  SD; y)
50-59 435 6.1
60-69 1938 27.0 1
70-79 3486 48.6 2
79 1313 18.3
Sex
Male 5764 80.4 3
Female 1408 19.6 1
Race
White 5204 72.5 3
Black 163 2.3
Other 330 4.6
Unspecified 1475 20.6 1
No. of comorbidities
0-1 4878 68.0 3
2-3 2198 30.6 1
4 96 1.4
Table II. Selected cardiovascular preoperative comorbid
conditions
Comorbid
condition
Open
(N  4607)
Endovascular
(N  2565)
Pn % n %
Diabetes 492 11 284 11 .61
Hypertension 2436 53 1463 57 .0007
Renal
insufficiency
312 7 87 3 .0001
COPD 1321 29 645 25 .001
Ischemic heart
disease
652 14 506 20 .0001
CVOD 19 0.4 17 0.7 .16
PAD 576 13 282 11 .06
ICD-9 codes for each comorbid condition can be found in the text.
COPD, Chronic obstructive pulmonary disease; CVOD, cerebrovascular
occlusive disease; PAD, peripheral arterial disease.Univariate analysis indicated that the type of surgery
(open vs endovascular), age, sex, and comorbid conditions
were highly significant independent predictors of the pri-
mary outcome measures of death, complications, and un-
favorable discharge. At multivariate analysis, however, in
descending order, only age, open repair, and female gender
posed a significant increased risk for each adverse outcome,
whereas preoperative comorbid conditions were a risk fac-
tor only for an unfavorable discharge to a facility. The
respective odds ratios with their confidence intervals are
given in Table IV.
The mean (2001) $50,346 vs $47,009;   $3337;
P .0009) and median ($42,147 vs $35,369;   $6778;
P  .0001) hospital charges for endovascular AAA repair
were significantly higher than for open repair. Extrapola-
tion of the mean difference to the estimated number of
endovascular AAA repairs performed in the United States,
on the basis of the sampling methods of the NIS database
(85% of all discharges from 20% of non-federal hospitals
l aortic aneuryam repair
Open Endovascular
P% n %
64 2565 36
1.9  7.7 73.4  7.8 .0001
6.9 116 4.5
27.8 656 25.6
49.3 1214 47.3
15.9 579 22.6 .0001
78.1 2164 84.4
21.9 401 15.6 .0001
71.1 1926 75.1
2.5 48 1.9
4.6 119 4.6 .138
21.8 472 18.4
68.1 1741 67.9
30.7 782 30.5
1.2 42 1.6 .258
Table III. Clinical outcomes after open vs endovascular
abdominal aortic aneuryam repair
Open Endovascular
Pn % n %
4607 64 2565 36
Death 176 3.8 33 1.3 .0001
Any complication 1317 28.6 456 17.8 .0001
Cardiac
complication
320 6.9 77 0.3 .0001
Length of stay
Mean  SD (d) 8.8 7.8 3.6 5.9 .0001
Median (d) 7 2 .0001
Disposition
Home 3773 81.9 2387 93.1
Institution 658 14.3 145 5.6 .0001mina
n
607
7
319
282
272
734
600
007
278
115
211
003
137
416
54
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year ($3337  15,088) resulted in a staggering $50.3
million in additional hospital charges.
DISCUSSION
All of the perioperative outcomes examined, including
mortality, complications, length of stay, and discharge dis-
position, strongly favor endovascular repair over open re-
pair. While decreased length of stay and risk for complica-
tions have been well-demonstrated in the various aortic
endograft pivotal trials,11,12,17,18 early mortality after en-
dovascular repair in these reports was either similar to or
only marginally improved over that with open repair.13
This was likely to the result of statistical analysis of relatively
small sample sizes of a low-incidence event, potentially
resulting in a type I error. The current study overcame these
limitations, and demonstrated for the first time not only a
highly significant statistical (P .0001) difference but also
an unequivocal numerical difference of nearly a threefold
reduction in perioperative mortality for endovascular repair
compared with open repair. Moreover, this difference was
realized in the face of a favorable open surgical mortality
rate of 3.8%, which is lower than most reported operative
mortality rates for elective open AAA repairs,19,20 but is still
consistent with our previous results of outcomes after open
AAA repair using the same database.16
Because of the nature of the NIS database, only in-
hospital mortality was captured, and 30-day mortality was
not. This could have resulted in a lower than actual endo-
vascular mortality, because patients were discharged rela-
tively early, and any deaths that occurred after discharge
would not have been captured by the database. On the
other hand, a significantly greater proportion of patients
were discharged to an institutional facility after open AAA
repair (14.3% vs 5.6%). As shown recently by Carey et al,21
who examined in-hospital mortality after cardiac surgery
using a state-specific hospital discharge database, more than
13% of the perioperative mortality occurred in the second-
ary facility to which the patient was transferred. This sug-
Histogram of inpatient length of stay for all survivors.gests that mortality after open repair could also have been
underestimated in the current study. Inasmuch as there are
no unique patient identifiers in the NIS database, there was
no method to cross-reference individual patients to any of
the available national death registries or to serially track
their hospitalizations and outcomes. Thus, given the com-
bination of potential factors that may have overestimated or
underestimated the current results and the relatively large
sample size of the two groups, we do not believe any
incremental change would materially alter the relative dif-
ference between the two mortality rates.
The 14% discharge rate to an institutional facility after
open repair in this study is also comparable to a previous
report by Williamson et al,22 in which 11% of patients
required transfer to a skilled nursing facility. In that study,
36% of patients who were independently ambulatory pre-
operatively either continued to require assistance or re-
mained nonambulatory at 2 years postoperatively. It is
remarkable that 18% of the patients in the study by William-
son et al would not undergo open repair again, even
knowing the consequences of AAA rupture. Thus, al-
though functional outcome is not an end point frequently
considered in most studies of AAA repair, survival alone
may be an inadequate measure of treatment success.
Multiple studies have compared the economics of
open versus endovascular repair.23,24 Despite significant
reductions in hospital stay and perioperative complica-
tions of endovascular repair, the high cost of the devices
(ranging from $10,000 to $12,000), life-long surveil-
lance with computed tomography, and 10% to 15% rate
of late secondary procedures6 have tipped the fiscal
balance in favor of open repair. Long-anticipated com-
petitive forces via the introduction of additional manu-
facturers in the aortic endograft market in the last 12
months (Excluder; Gore, Sunnyvale, Calif;Zenith;
Cook, Bloomington, Ind) have disappointingly failed to
lower the cost of these devices.
Whereas most previous studies by US authors compar-
ing open versus endovascular repair have used hospital
costs,23,24 in the current study only charges incurred dur-
ing inpatient hospitalization were available. Although re-
porting costs have been favored over charges, because of
potentially greater generalizability, variances in accounting
and definitions of what constitutes acute treatment–related
costs have resulted in large differences in actual dollars
among reports.23,24 However, charges being higher than
costs in general, our reported difference in mean charges of
(2001) $3337 may be conservatively interpreted as the
upper limit of the mean difference of cost between the two
procedures. Of interest, this difference is less than half of a
cost-based analysis previously published using the Medicare
Provider Analysis and Review (MEDPAR) database
([2001] $3337 vs [1999] $7439).23
Limitations of this study are directly related to the use
of an administrative database to examine clinical outcomes;
such databases were never intended for this function. One
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other administrative databases is the completeness and
accuracy of the codes, which are usually abstracted by
nonclinical personnel. While discrete end points such as
in-hospital mortality are generally accurate, preoperative
comorbid conditions and postoperative complications are
subject to certain human interpretation and oversight, be-
cause of the sheer diversity of individual and locoregional
descriptors. This limitation is exemplified when the overall
incidences of comorbid conditions of the open and endo-
vascular groups from the NIS database are compared with
historic demographic data obtained from two US pivotal
endograft trials.1,17 While most were similar, the category
of ischemic heart disease was grossly different (clinical trials,
60%, vs NIS database, 16%). This is likely due to differing
definitions of such broad terms as ischemic heart disease or
coronary artery disease. On the other hand, these effects are
likely attenuated within the confines of the NIS database by
the sheer large number of observations that are available for
statistical analysis, which tends to “randomize” these sys-
tematic errors between the study cohorts and thus mini-
mize the chances of a type II error.
Table IV. Multivariate analysis of independent predictors
Outcome Odds ratio
Death
Type of repair (vs endovascular)
Open 3.3
Age (vs 50-60 y)
60-70 3.8
70-80 6.8
80 14.1
Sex (vs female)
Male 0.69
Comorbidities (vs 0-1)
2-3 0.98
4-5 2.4
Complication
Type of repair (vs endovascular)
Open 1.9
Age (vs 50-60 y)
60-70 1.2
70-80 1.5
80 1.9
Sex (vs female)
Male 0.85
Comorbidities (vs 0-1)
2-3 0.95
4-5 1.1
Discharge to Home
Type of repair (vs endovascular)
Open 3.4
Age (vs 50-60 y)
60-70 2.0
70-80 5.0
80 12.0
Sex (vs female)
Male 0.47
Comorbidities (vs 0-1)
2-3 1.1
4-5 2.2The method of selection of the particular ICD-9 codes
to identify index cases has also been previously validated
with data from the authors’ own institutional database,
which were subsequently cross-referenced with actual case
records. This demonstrated that the selection criteria re-
sulted in an overall accuracy of 94% in identification of
intact AAAs, exclusive of more rare aortic aneurysm dis-
ease.16 As a way of internally validating our method, when
all 15 “possible” ICD-9 procedure codes for aortic aneu-
rysm repair were used to analyze the primary end points of
the current study, it yielded an additional 965 open repairs,
for a total of 5572 cases (ICD-9 code 38.44: 4607 plus
965). In this “superset,” the mortality rate was 3.9% (vs
3.8% for ICD-9 code 38.44 alone), the complication rate
was 28.3% (vs 28.6%), and mean length of stay was 8.7 days
(vs 8.8 days).
In summary, endovascular repair of intact AAA yields
superior perioperative results compared with open surgical
repair, with respect to length of stay, complications, discharge
disposition, and, most important, mortality. However, these
gains in early clinical outcomes are balanced by more than $50
million per year in additional hospital charges.
verse outcome
95% Confidence interval P
.0001
2.3, 4.9
.0001
0.90, 15.8
1.7, 27.8
3.5, 58.1
.016
0.51, 0.93
.128
0.73, 1.3
1.0, 5.7
.0001
1.7, 2.1
.0001
0.92, 1.6
1.1, 1.9
1.5, 2.5
.016
0.74, 0.97
.592
0.84, 1.1
0.69, 1.7
.0001
2.9, 4.1
.0001
1.2, 3.5
3.0, 8.5
7.0, 20.4
.0001
0.41, 0.55
.008
0.91, 1.2
1.3, 3.7of ad
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